FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Bexson Biomedical
Recent news which mentions Bexson Biomedical
EXCLUSIVE: Ketamine Therapy Leaders Share Bold Vision For Future At Benzinga's Psychedelics Capital Conference
April 14, 2023
Tickers
RVLWF
Tags
Market News
FDA
Legal
From
Benzinga
New At-Home Multiple Drugs Formulation Delivery Technology Scores US Patent
September 16, 2022
Tags
Markets
Jeffrey Becker
Cannabis
From
Benzinga
EXCLUSIVE: Bexson Biomedical's CSO Says Subcutaneous Ketamine Could Treat Wide Range Of Health Issues
May 18, 2022
Tags
News
Exclusives
Cannabis
From
Benzinga
EXCLUSIVE: Bexson Biomedical Inks Agreement With Stevanato For Delivery System Of Ketamine In Pain Management
April 28, 2022
Tags
Mauro Stocchi
Exclusives
Stevanato Group
From
Benzinga